Hemispherian
Monika Hegi is a Full Professor at CHUV | Lausanne University Hospital since January 1998, specializing in translational research for glioma, focusing on gene expression profiling and epigenetic alterations to identify predictive factors for therapy response. Concurrently, Monika Hegi serves as a Full Professor and Associate Professor at the University of Lausanne - UNIL, with a research emphasis on experimental and translational cancer research in neuro-oncology, particularly tumor epigenetics and clinical trials. Previous positions include Senior Research Associate at Universitätsspital Zürich and Postdoctoral Research Associate at NIEHS. Monika Hegi holds a Ph.D. in Natural Sciences - Biology and a Master's Degree from ETH Zürich.
This person is not in the org chart
This person is not in any offices
Hemispherian
Hemispherian is a biotechnology company developing new treatments for the most aggressive types of cancer. Its mission is to development a new drug to treat Glioblastoma Multiforme.